Abrezekimab - HY-P99417
Nur noch %1 verfügbar
Catalog #
HY-P99417
Ab
258,00 €
Abrezekimab (VR 942) contains CDP7766, a humanized, high-affinity, neutralizing, anti-human-IL-13 antibody fragment that binds to IL-13. Abrezekimab prevents binding to the IL-13Rα1 subunit. Abrezekimab can be used in research of asthma[1].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-P99417/Abrezekimab-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Dry Ice |
| Application | COVID-19-immunoregulation |
| Alternative Names | UCB4144; VR 942 |
| CAS | 2043952-59-4 |
| Storage | Store at -80°C for 2 years |
| MWT | N/A |
| Solubility | 10 mM in DMSO |
| Clinical Information | Phase 1 |
| Target | Interleukin Related |
| Application: | COVID-19-immunoregulation |
|---|